AstraZeneca vs Qdrant

AstraZeneca (Data and AI: Unlocking new science insights) and Qdrant (Creating advanced vector search technology) both appear on the Smoower Developer Ecosystem Index.

Qdrant (rank #5) holds a meaningful lead over AstraZeneca (rank #532) on the overall Smoower ecosystem score (74 vs 37). The gap of 37 points reflects composite signals across code, docs, community and reach.

On code quality (the state of repositories, tests, releases and polish), Qdrant is ahead of AstraZeneca. On education (docs, guides and learning material for developers), Qdrant is ahead of AstraZeneca. On community (issue response, PR reviews and discussion health), Qdrant is clearly ahead of AstraZeneca. On reach (how visible the ecosystem is beyond its own repos), Qdrant is clearly ahead of AstraZeneca. On momentum (release cadence and how fast the ecosystem moves), Qdrant is clearly ahead of AstraZeneca.

AstraZeneca carries 5,191 GitHub stars across 110 public repos, with 18 repositories active in the last 90 days and 2 external contributors on record. Qdrant shows 45,822 stars across 132 public repos, 89 active in the last 90 days and 122 external contributors. The star gap on its own does not decide the comparison, but Qdrant's footprint is roughly 8.8x larger, which usually shows up in downstream signals like inbound issues and third party integrations.

AstraZeneca is worth a look for teams already invested in its stack. Qdrant looks better where reach is the deciding factor. The table below breaks the scores down pillar by pillar; the linked profiles cover the underlying repos, docs and community signals in full.